Latest Beauty And Wellness News

Adore Beauty Group reports a 7.4% revenue rise in FY26 despite market headwinds and outlines ambitious FY27 targets backed by new stores and operational efficiencies.

Amcor posted a 77% jump in Q3 net sales fueled by the Berry acquisition, delivering synergy gains above expectations and updating fiscal 2026 guidance amid geopolitical headwinds.

McPherson’s Limited has confirmed a $3.3 million total tax benefit following amended assessments by the ATO, linked to deductible costs from a strategic alliance announced in 2022.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Anagenics Limited has announced a two-tranche placement to raise A$2.25 million, aiming to expand its health and wellness brands while retiring debt and supporting working capital.

Amcor’s first quarter fiscal 2026 results showcase strong growth driven by the Berry Global acquisition, with sales up 68% and synergies exceeding expectations. The company also raised its dividend and reaffirmed its full-year guidance.

Anagenics Limited reports a notable improvement in operating cash outflows for 1Q26, driven by cost efficiencies and strong brand performance, with Bouf Haircare on track to exceed $9 million in sales.

Biome Australia has secured key distribution partnerships with Mecca and Go Vita, launching its Activated Probiotics range into premium beauty and health food channels across Australia.

McPherson’s Limited has finalized a key pharmacy wholesaler agreement with API Services Australia, marking the completion of its new distribution model and transitioning significant revenue previously handled direct-to-store.

Amcor has completed its transformative acquisition of Berry Global, reporting a 43% jump in quarterly net sales and projecting strong earnings growth for fiscal 2026. The company’s strategic portfolio review and synergy realisation efforts underpin an optimistic outlook.

Anagenics Limited has reported a net profit before tax of $138,000 for the quarter ended March 31, 2025, marking a significant turnaround following recent restructuring efforts. Despite a temporary revenue setback due to a warehousing transition, the company’s operating cash flow improved markedly.

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.